Ahmed valve implant and its place in the surgical treatment of glaucoma

Author:

Oblovatskaya E. S.1,Nikolaenko V. P.2

Affiliation:

1. Saint Petersburg General Hospital No. 2

2. Saint Petersburg General Hospital No. 2; Saint Petersburg State University

Abstract

PURPOSE. To determine the indications for Ahmed glaucoma valve implantation by analyzing the duration and regimen of hypotensive therapy, and the configuration of previous interventions.METHODS. Retrospective evaluation of the duration and intensity of therapeutic treatment, and the configuration of laser and surgical procedures in a group of 139 patients (153 interventions) who underwent Ahmed glaucoma valve implantation in 2009–2011, and another group of 270 patients (272 interventions) who were treated in 2019–2010.RESULTS. The average age of candidates for implantation of the Ahmed valve increased from 63 y.o. in 2009–2011 to 70 y.o. in 2019–2020. The treatment preceding Ahmed valve implantation had extended in duration from 8.8±1.4 to 11.2±1.1 years leading to an increase in cumulative preservative toxicity from 9 293.8±968.6 to 10 038.1±888.9 µg. The main classes of intraocular pressure (IOP)-lowering drugs were prostaglandin analogues (75.4% in 2009–2011 and 77.1% in 2019–2020), carbonic anhydrase inhibitors (75.4% and 82.6%), and beta-blockers (57.4% and 61.1% accordingly). Laser trabeculoplasty was performed in only 11.8% and 28.7% of cases, respectively. Hypotensive filtering operations preceded valve implantation in 63.4% (2009–2011) and 80.5% of cases (2019–2020), while in the rest of patients the installation of the Ahmed device was the first surgical procedure. Despite treatment, the rate of glaucoma progression to an advanced stage increased from 62.1% in 2009–2011 to 82.7% in 2019–2020.CONCLUSION. With increase in the duration of conservative management of glaucoma its progression continues, while the increased preservative toxicity reduces the effectiveness of conjunctival surgery. In conclusion, earlier switch to surgical methods of IOP normalization involving the use of the Ahmed valve is advisable not only in secondary, but also in primary open-angle glaucoma treated conser-vatively for a long (over 7–8 years) period.

Publisher

Research Institute of Eye Diseases

Reference21 articles.

1. Clinical recommendations. Primary open-angle glaucoma. 2020. URL: http://avo-portal.ru/documents/fkr/odobr/ПОУГ.pdf (accessed: 11.01.2022). (In Russ.)

2. Natsional'noe rukovodstvo po glaukome dlya praktikuyushhikh vrachei. Izd. 4-e, ispravlennoe i dopolnennoe. [National glaucoma guidelines for practicing doctors. 4th edition]. Edited by: E.A. Egorov, V.P. Erichev. Moscow, GEOTAR-Media Publ., 2019. 384 p. (In Russ.)

3. European Glaucoma Society: Terminology and Guidelines for Glaucoma (5th Edition). Savona, PubliComm, 2020. 169 p.

4. Tan H., Kang X., Lu S., et al. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. PLoS ONE 2015; 10(2):e0118142. https://doi.org/10.1371/journal.pone.0118142

5. Luzu J., Baudouin C., Hamard P. The role of Ahmed glaucoma valve in the management of refractory glaucoma: Long-term outcomes and complications. Eur J Ophthalmol 2020; 1120672120968733. https://doi.org/10.1177/1120672120968733

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3